Increased bone resorption in patients with Crohn's disease

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 8, 1998, Pages 699-705

  Robinson, R J ^a   Iqbal, S J ^b   Abrams, K ^c   Al Azzawi, F ^b   Mayberry, J F ^a  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; DEOXYPYRIDINOLINE; OSTEOCALCIN;

ARTICLE; BONE TURNOVER; CLINICAL TRIAL; COLLAGEN DEGRADATION; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL;

ADULT; AMINO ACIDS; BIOLOGICAL MARKERS; BONE DENSITY; BONE RESORPTION; CROHN DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS;

EID: 0031819998     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00364.x     Document Type: Article

References (22)

1. Jahnsen J, Falch J, Aadland E, Mowinckel P. Bone mineral density is reduced in patients with Crohn's disease hut not in patients with ulcerative colitis: a population based study. Gut 1997; 40: 313-19.
2. Ghosh S, Cowen S, Hannan W, Ferguson A. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 1994; 107: 1031-9.
3. Compston J. Review article: osteoporosis, corticosteroids and inflammatory bowel disease. Aliment Pharmacol Ther 1995; 9(5): 237-50.
4. Hessov I, Mosekilde L, Melsen F. Osteopenia with normal vitamin D metabolites after small bowel resection for Crohn's disease. Scand J Gastroenterol 1984; 19: 691-6.
5. Croucher P, Vedi S, Motley R, Garrahan N, Stanton M, Compston J. Reduced hone formation in patients with osteoporosis associated with inflammatory bowel disease. Osteoporosis Int 1993; 3(5): 236-41.
6. Blumsohn A, Eastell R. The performance and utility of biochemical markers of hone turnover: do we know enough to use them in clinical practice? Ann Clin Chem 1997; 34(5): 449-59.
7. Kjeldsen J, Junker P, Schaffalitzky de Muckadell O. Evidence that collagen 1 turnover is increased in active Crohn's disease. Gastroenterology 1994; 104(Suppl. 4): A712(Abstract).
8. Abitbol V, Roux C, Chaussade S, et al. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 1995; 108: 417-22.
9. Silvennoinen J, Ristelli L, Karttunen T, Risteli J. Increased degradation of type I collagen in patients with inflammatory bowel disease. Gut 1996; 38: 223-8.
10. Bjarnason I, Macpherson A, Mackintosh C, Buxton-Thomas M, Forgacs I, Moniz C. Reduced hone density in patients with inflammatory bowel disease. Gut 1997; 40: 228-33.
11. Hyams J, Wyzga N, Kreutzer D, Justinich C, Gronowicz G. Alterations in bone metabolism in children with inflammatory bowel disease: an in vitro study. J Pediatr Gastroenterol Nutr 1997; 24(3): 289-95.
12. Harvey R, Bradshaw J. A simple index of Crohn's disease activity. Lancet 1980; March 8th: 514.
13. Bernstein C, Seeger L, Sayre J, Anton P, Artinian L, Shanahan F. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Min Res 1995: 10(2): 250-5.
14. Lukert B, Raisz L. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990; 112(5): 352-64.
15. Godschalk M, Downs R. Effect of short-term glucocorticoids on serum osteocalcin in healthy young men. J Bone Min Res 1988; 3: 113-15.
16. Lin C, Moniz C, Chambers T, Chow J. Colitis causes bone loss in rats through suppression of bone formation. Gastroenterology 1996; 111: 1263-71.
17. Uebelhart D, Schlemmer A, Johansen J, Gineyts E, Christiansen C, Delmas P. Effect of menopause and hormone replacement on the urinary excretion of pyridinum crosslinks. J Clin Endocrinol Metab 1991; 72: 367-73.
18. van Daele PLA, Siebel MJ, Burger H, et al. Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study. Rr Med J 1997; 312: 482-3.
19. Vogelsang H, Ferenci P, Resch H, Kiss A, Gangl A. Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation. Eur J Gastroenterol Hepatol 1995; 7(7): 609-14.
20. Clements D, Compston J, Evans W, Rhodes J. Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease. Gut 1993; 34: 1543-6.
21. Robinson R, Krwyzicki T, Almond L, et al. The effect of low impact exercise on bone mineral density in patients with Crohn's disease. A randomised controlled study. Gut 1997; 41(Suppl. 3): A17(Abstract).
22. Adami S, Zamberlan N. Adverse effects of bisphosphonates. Drug Safety 1996; 14: 158-70.